SCHEMBL6177506

SCHEMBL6177506

CC(C)(C)OC(=O)Nc1cccc(OC(C)(C)C(=O)O)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PPARA Q07869 5/20 0.48
▸ PPARG P37231 3/20 0.48
▸ PPARD Q03181 2/20 0.48
▸ HDAC3 O15379 1/20 0.46
▸ HDAC1 Q13547 1/20 0.46
▸ HDAC2 Q92769 1/20 0.46
▸ HDAC8 Q9BY41 1/20 0.46
▸ HDAC6 Q9UBN7 1/20 0.46
▸ CYP1A2 P05177 1/20 0.45
▸ CYP17A1 P05093 1/20 0.45
▸ LMNA P02545 2/20 0.44
▸ POLB P06746 1/20 0.44
▸ KAT6A Q92794 1/20 0.44
▸ MAPK1 P28482 2/20 0.44
▸ FAAH O00519 1/20 0.44
▸ ALDH1A1 P00352 1/20 0.44
▸ CYP3A4 P08684 1/20 0.44
▸ RXFP1 Q9HBX9 1/20 0.44
▸ NPC1 O15118 2/20 0.43
▸ RAB9A P51151 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29991055 0.84 NPC1 (0.55) LMNAPOLBALDH1A1RXFP1NPC1
SCHEMBL27833511 0.84 NPC1 (0.55) LMNAPOLBALDH1A1RXFP1NPC1
SCHEMBL2655466 0.84 SMN1; SMN2 (0.55) PPARAPPARGPPARDCYP1A2LMNA
SCHEMBL2655891 0.83 PPARA (0.53) PPARAPPARGHDAC3HDAC1HDAC2
SCHEMBL3892771 0.83 ALDH1A1 (0.52) HDAC3HDAC1HDAC2HDAC8HDAC6
SCHEMBL281590 0.82 RAB9A (0.59) LMNAPOLBMAPK1ALDH1A1RXFP1
SCHEMBL6180358 0.82 MGLL (0.50) PPARAPPARGPPARDCYP1A2KAT6A
SCHEMBL29029431 0.82 HDAC3 (0.56) HDAC3HDAC1HDAC2HDAC8HDAC6
SCHEMBL11176132 0.81 TP53 (0.52) PPARAPPARGPPARDHDAC6LMNA
SCHEMBL5894005 0.80 CA2 (0.52) HDAC3HDAC1HDAC2HDAC8HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0945445-B9 1,5-BENZODIAZEPINE DERIVATIVES ZERIA PHARM CO LTD (JP) 2005-12-28 — — EP disclosed
EP-0945445-B1 1,5-BENZODIAZEPINE DERIVATIVES ZERIA PHARM CO LTD (JP) 2003-09-03 — — EP disclosed
US-6239131-B1 WHICH HAVE GASTRIN AND/OR CCK-B (CHOLECYSTOKININ-B) RECEPTOR ANTAGONISM, USEFUL AS REMEDIES FOR GASTRIC ULCER AND GASTROINTESTINAL MOVEMENT DISORDER. ZERIA PHARMACEUTICAL CO., LTD. (JP) 2001-05-29 — — US disclosed
EP-0945445-A1 1,5-BENZODIAZEPINE DERIVATIVES ZERIA PHARMACEUTICAL CO., LTD. (JP) 1999-09-29 — — EP disclosed
Send feedback